<DOC>
	<DOCNO>NCT01050751</DOCNO>
	<brief_summary>This randomize study ass whether pharmacokinetics new single 750 mg tablet similar 3 x 250 mg tablet ( 750 mg total ) .</brief_summary>
	<brief_title>Bioavailability Of Lersivirine Single 750 Mg Tablet Versus 3 X 250 Mg Tablets</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 . Total body weight &gt; 50 kg ( 110 lb ) . Treatment investigational drug within 30 day 5 halflives local regulation ( whichever longer ) precede first dose study medication . Use prescription nonprescription drug dietary supplement within 7 day 5 halflives ( whichever longer ) prior first dose study medication . History regular alcohol consumption exceed 14 drinks/week woman 21 drinks/week men ( 1 drink = 150 mL wine 360 mL beer 45 mL hard liquor ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Bioavailability</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Lersivirine</keyword>
	<keyword>UK-453</keyword>
	<keyword>061</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>